Today’s ASH highlight video is on Cevostamab-a fixed duration bispecific antibody that targets FCRH5 youtu.be/kHNBPB1S7QY?... #MMsm #ASH24 #HealthTree #myeloma
youtu.be
Cevostamab, a FcRH5 bispecific antibody, for RRMM | Joshua Richter, MD | #ASH2024
YouTube video by HealthTree Foundation for Multiple Myeloma